RecruitingNCT03539133

Systemic Organ Communication in STEMI


Sponsor

Heinrich-Heine University, Duesseldorf

Enrollment

1,000 participants

Start Date

Oct 18, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

Despite progress in pre-hospital care, ambulance logistics, pharmacotherapy and PPCI techniques, ST-segment elevation myocardial infarction (STEMI) continues to confer a substantial burden of morbidity and mortality. Within the STEMI population, there is a spectrum of higher and lower risk patients. The aim of this cohort study is to collect prospectively and systematically clinical research data from STEMI patients. This cohort study is an open-end observational study to identify master switches in myocardial ischemia.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying collection of clinical data for people with st-segment elevation myocardial infarction (stemi). The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERcollection of clinical data

prospectively and systematically collection of clinical research data from STEMI patients


Locations(1)

Division of Cardiology, Pulmonary Disease and Vascular Medicine

Düsseldorf, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03539133


Related Trials